{"id":"W3152988358","doi":"10.1016/s2213-2600(21)00097-7","title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"letter","venue":"The Lancet Respiratory Medicine","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":580,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Allergy Therapeutics; Novartis; GlaxoSmithKline","keywords":"Medicine; Nasal polyps; Mepolizumab; Chronic rhinosinusitis; Placebo; Double blind; Internal medicine; Randomized controlled trial; Gastroenterology; Asthma; Alternative medicine; Pathology; Eosinophil","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001692606,0.001043451,0.002358396,0.0002078561,0.0004496286,0.0008901585,0.0006598362,0.004089444,0.006411876],"category_scores_gemma":[0.002514626,0.0004345004,0.001697245,0.0002506098,0.0006364222,0.0007968385,0.000294004,0.002968238,0.00122218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006816263,"about_ca_system_score_gemma":0.0008067837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001077501,"about_ca_topic_score_gemma":0.003580119,"domain_scores_codex":[0.9994546,0.0002779544,0.00004303612,0.00008471701,0.00005846948,0.00008121508],"domain_scores_gemma":[0.9992023,0.0003523962,0.0001564052,0.00003782754,0.00005733165,0.0001937928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.932175,0.001672643,0.0008996244,0.003218327,0.002385396,0.0003361925,0.00008683398,0.0001691993,0.003284026,0.0003742062,0.01529135,0.04010723],"study_design_scores_gemma":[0.985662,0.009408328,0.001339316,0.0001106387,0.0005061909,0.00008306852,0.00001563567,0.000114116,0.0001168595,0.0001658199,0.00246649,0.00001139929],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8400451,0.08656091,0.001952003,0.0295555,0.0142431,0.006775255,0.005155212,0.0004303691,0.0152825],"genre_scores_gemma":[0.9156145,0.02004735,0.002885025,0.03418186,0.005299675,0.006054301,0.001892525,0.00005790347,0.01396685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006411876,"threshold_uncertainty_score":0.02144986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1069885515465855,"score_gpt":0.3699421946416087,"score_spread":0.2629536430950232,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}